Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Borealis Ventures is a venture capital firm founded in 2002 and based in Hanover, New Hampshire. The firm focuses on partnering with entrepreneurs to build companies that aim to transform healthcare through new therapies, digital innovation, and other technologies. Borealis Ventures has a legacy of advancing entrepreneurship at Dartmouth College, which serves as a key sourcing channel for investments. The firm has consistently invested in early-stage companies, primarily in the healthcare sector, and has established a reputation for supporting innovative solutions in life sciences.
As of now, Borealis Ventures manages a portfolio of 40 companies and has raised multiple funds since its inception. The firm operates as lifecycle investors, providing support from pre-seed through Series A stages. Borealis Ventures has a strong commitment to fostering entrepreneurship and innovation, particularly in northern New England, while also expanding its geographic focus toward New York and California.
Borealis Ventures invests primarily in the healthcare sector, with a specific emphasis on life science platforms, digital health, and animal health. The firm operates as lifecycle investors, which means they engage with companies at various stages of development, from pre-seed to Series A. Check sizes typically range from $250,000 to $750,000 per investment, allowing for flexibility in supporting emerging companies.
The firm collaborates with syndicate partners to provide comprehensive resources to its portfolio companies, enhancing their chances of success. Borealis Ventures seeks entrepreneurs who are dedicated to transforming healthcare through innovative therapies and technologies. Their investment strategy is informed by a strong network from Dartmouth University, which plays a crucial role in sourcing deals and fostering relationships within the healthcare innovation space.
Borealis Ventures has backed a diverse range of companies in the healthcare sector, showcasing its commitment to innovation and growth. Notable exits from their portfolio include:
Additionally, Borealis Ventures has invested in companies such as those merged with Wedgewood and acquired by Altaris, further demonstrating their active role in the healthcare investment landscape.
Phil Ferneau - Partner. Phil is a co-founder and Managing Director at Borealis Ventures, leading healthcare investing. He holds an undergraduate degree from Dartmouth College and an MBA from the Tuck School of Business.
Ben Shaw - Partner. Ben brings extensive experience in venture capital and has been instrumental in shaping the firm's investment strategy.
Julia Stephanus - Partner. Julia has a strong background in healthcare investments and plays a key role in sourcing and evaluating new opportunities.
Emily Snyder - Principal. Emily is a Tuck MBA graduate and focuses on supporting portfolio companies and identifying new investment opportunities.
Chris Lites - Venture Fellow. Chris contributes to the firm's investment analysis and portfolio management efforts.
Peter Bertone - Venture Fellow. Peter assists in evaluating potential investments and supporting existing portfolio companies.
Dave Whitehead - Venture Consultant. Dave provides strategic insights and guidance to the firm and its portfolio companies.
Ernie Tao - Venture Fellow. Ernie supports the investment team in various capacities, focusing on healthcare innovation.
To pitch Borealis Ventures, founders should send an email to team@borealis.vc. A concise pitch deck is recommended, including key information such as the business model, market analysis, competitive landscape, and team background. Founders should expect a response within a few weeks, and warm introductions through mutual connections are encouraged to enhance the likelihood of engagement.
In recent months, Borealis Ventures has continued to focus on healthcare innovation, actively seeking new investment opportunities in the sector. The firm has maintained its commitment to supporting early-stage companies, particularly those emerging from the Dartmouth University network. Notable portfolio companies have achieved significant milestones, including public listings and acquisitions, reflecting the firm's successful investment strategy.
As of October 2023, Borealis Ventures remains engaged in the venture capital landscape, with ongoing discussions about potential new funds and partnerships aimed at expanding their reach and impact in the healthcare sector.
What are Borealis Ventures' investment criteria?
Borealis Ventures primarily invests in early-stage healthcare companies, focusing on life sciences, digital health, and animal health. They look for entrepreneurs who are committed to transforming healthcare through innovative therapies and technologies.
How can I apply or pitch to Borealis Ventures?
Founders can reach out to Borealis Ventures via email at team@borealis.vc. A well-prepared pitch deck that outlines the business model, market opportunity, and team background is essential for consideration.
What makes Borealis Ventures different from other VC firms?
Borealis Ventures leverages a strong network from Dartmouth University, which aids in sourcing deals and providing resources to portfolio companies. Their focus on healthcare innovation and early-stage investments sets them apart in the venture capital landscape.
What is the geographic scope of Borealis Ventures?
The firm primarily invests in the United States, with a historical focus on northern New England. However, they are expanding their reach toward New York and California to tap into broader healthcare innovation hubs.
What is the typical check size for investments?
Borealis Ventures typically invests between $250,000 and $750,000 per company, allowing them to support a range of early-stage ventures effectively.
What kind of post-investment involvement can founders expect?
Borealis Ventures provides comprehensive resources and support to its portfolio companies, leveraging its network and expertise in healthcare to assist entrepreneurs in building successful businesses.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.